Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
◆ French pharma prints along liquid parts of the curve ◆ Two shorter tranches land flat to fair value ◆ Danaher showed demand for high rated issuers earlier in the week -
◆ Safer credits prove popular in uncertain market ◆ Alliander sheds orders as it punches through fair value ◆ Argan ends near five year euro absence
-
Lull in dollar corporate supply supports spread levels
-
Red-hot corporate hybrid bond market could tempt more debut issuers
-
◆ Pearson pays up to reopen UK sterling paper ◆ Investors hungry for scant sterling supply ◆ Fellow UK media firm Informa opts for euros
-
◆ Norwegian issuer returns to hybrid market after 2023 debut ◆ Issuer slashes spread by 62.5bp ◆ €5bn peak book drives pricing through fair value
Sub-sections
